With the recent spike in demand surrounding these medications, HR decision-makers feel it will create a better health insurance package overall for employees, as well as boost their mental and physical health long-term, Wantuck told SHRM Online last month, noting that more than two-thirds of companies that added GLP-1s to their health care offerings experienced an increase in enrollment
Recently, a double-blind, randomized, placebo-controlled trial Glucagon-like peptide-1 receptor Agonist Treatment in Adult, obesity-replated, symptomatic asthma (GATA-3) was funded by the National Institutes of Allergy and Infectious Diseases (U01AI15529901)
What are the clinical signs that indicate the need for Vitamin B12 injections
Will weight loss change how much levothyroxine I need
6-8 Jobs Investment Retail Data Spirits Newsletter PR Submit News Login Become an Insider Become a BevNET/NOSH Insider Today